Published • loading... • Updated
OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B
The startup is expected to focus on drug discovery, with Lightspeed in talks to lead a round that could value it at $2 billion.
Summary by TechCrunch
7 Articles
7 Articles
Miles Wang leaves OpenAI for a $2bn AI drug startup
No name. No product. No confirmed funding. And, possibly, a $2bn price tag. That is the shape of the newest bet in AI drug discovery. Miles Wang, a researcher at OpenAI, is leaving to start his own company, TechCrunch reported. He is in talks to raise about $200m at a $2bn valuation, with Lightspeed in […] This story continues at The Next Web
·Amsterdam, Netherlands (Kingdom of the)
Read Full Article
TechCrunch+4 Reposted by 4 other sources
OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B
Lightspeed is in discussions to lead the funding round, sources say.
·San Francisco, United States
Read Full Article
Miles Wang, former OpenAI researcher, leaves the company to launch an AI drug startup and targets a $200 million round
·Romania
Read Full ArticleCoverage Details
Total News Sources7
Leaning Left1Leaning Right0Center1Last UpdatedBias Distribution50% Left, 50% Center
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
50% Center
L 50%
C 50%
Factuality
To view factuality data please Upgrade to Premium
